Stay updated on TEPEZZA Post-Marketing Requirement Study Clinical Trial
Sign up to get notified when there's something new on the TEPEZZA Post-Marketing Requirement Study Clinical Trial page.

Latest updates to the TEPEZZA Post-Marketing Requirement Study Clinical Trial page
- Check5 days agoChange DetectedThe TEPEZZA post-marketing study record is displayed, including its design, eligibility criteria, locations, outcomes, and data-sharing details.SummaryDifference69%

- Check12 days agoChange DetectedThe site footer revision changed from v3.7.2 to v3.8.0. The page still displays a 403 Forbidden error instead of the study record.SummaryDifference0.2%

- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedAn NIH-wide notice about terminology changes appears above the 403 error page, and the site revision identifier changes from v3.7.1 to v3.7.2.SummaryDifference1%

- Check40 days agoChange DetectedThe site footer revision label changes from v3.7.0 to v3.7.1. The page otherwise remains a 403 error page.SummaryDifference0.2%

- Check54 days agoChange DetectedThe page now displays a 403 Forbidden error message, replacing the study record content with a generic header/footer. The main content and related links have been removed, leaving only site chrome and the error notice.SummaryDifference19%

- Check61 days agoChange DetectedThe page revision label was updated from v3.6.6 to v3.7.0, signaling a version update of the page template/system. This change reflects an update to the page framework rather than a modification to study data or content.SummaryDifference0.0%

Stay in the know with updates to TEPEZZA Post-Marketing Requirement Study Clinical Trial
Enter your email address, and we'll notify you when there's something new on the TEPEZZA Post-Marketing Requirement Study Clinical Trial page.